Chromadex Corp
NASDAQ:CDXC
Balance Sheet
Balance Sheet Decomposition
Chromadex Corp
Current Assets | 49.5m |
Cash & Short-Term Investments | 27.2m |
Receivables | 5.2m |
Other Current Assets | 17.1m |
Non-Current Assets | 5.4m |
PP&E | 4.5m |
Intangibles | 510k |
Other Non-Current Assets | 383k |
Current Liabilities | 20.6m |
Accounts Payable | 10.2m |
Accrued Liabilities | 10.2m |
Other Current Liabilities | 206k |
Non-Current Liabilities | 5.9m |
Long-Term Debt | 12k |
Other Non-Current Liabilities | 5.9m |
Balance Sheet
Chromadex Corp
Jan-2015 | Jan-2016 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
4
|
6
|
2
|
45
|
23
|
19
|
17
|
28
|
20
|
27
|
|
Cash |
4
|
6
|
2
|
45
|
23
|
19
|
17
|
28
|
20
|
27
|
|
Total Receivables |
2
|
2
|
6
|
5
|
5
|
2
|
3
|
5
|
8
|
5
|
|
Accounts Receivables |
2
|
2
|
6
|
5
|
4
|
1
|
2
|
3
|
5
|
2
|
|
Other Receivables |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
3
|
3
|
|
Inventory |
4
|
8
|
8
|
6
|
8
|
12
|
12
|
14
|
15
|
15
|
|
Other Current Assets |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
|
Total Current Assets |
10
|
17
|
16
|
57
|
37
|
34
|
32
|
49
|
47
|
50
|
|
PP&E Net |
1
|
2
|
3
|
3
|
4
|
5
|
4
|
7
|
6
|
5
|
|
PP&E Gross |
1
|
2
|
3
|
3
|
4
|
5
|
4
|
7
|
0
|
5
|
|
Accumulated Depreciation |
3
|
3
|
3
|
1
|
2
|
3
|
4
|
5
|
0
|
5
|
|
Intangible Assets |
0
|
0
|
0
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
|
Note Receivable |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
|
Total Assets |
12
N/A
|
19
+63%
|
20
+5%
|
63
+218%
|
42
-33%
|
40
-5%
|
38
-5%
|
58
+51%
|
54
-7%
|
55
+2%
|
|
Liabilities | |||||||||||
Accounts Payable |
3
|
6
|
6
|
4
|
10
|
10
|
9
|
10
|
10
|
10
|
|
Accrued Liabilities |
1
|
1
|
2
|
4
|
4
|
5
|
7
|
7
|
8
|
10
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Liabilities |
5
|
10
|
9
|
8
|
14
|
15
|
16
|
18
|
18
|
21
|
|
Long-Term Debt |
2
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
0
|
1
|
0
|
0
|
5
|
5
|
9
|
7
|
6
|
|
Total Liabilities |
8
N/A
|
13
+79%
|
10
-27%
|
9
-9%
|
15
+69%
|
20
+32%
|
22
+11%
|
26
+19%
|
25
-3%
|
27
+4%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
40
|
42
|
45
|
57
|
90
|
122
|
142
|
169
|
185
|
190
|
|
Additional Paid In Capital |
43
|
47
|
55
|
110
|
117
|
142
|
158
|
201
|
214
|
219
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
4
N/A
|
5
+32%
|
10
+89%
|
54
+440%
|
27
-50%
|
20
-25%
|
16
-20%
|
32
+93%
|
29
-10%
|
28
-1%
|
|
Total Liabilities & Equity |
12
N/A
|
19
+63%
|
20
+5%
|
63
+218%
|
42
-33%
|
40
-5%
|
38
-5%
|
58
+51%
|
54
-7%
|
55
+2%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
35
|
36
|
38
|
55
|
55
|
60
|
62
|
68
|
75
|
75
|